43 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Opportunistic Disease in HIV-AIDS ... (TB) • Disseminated ... #OIs #HIVAIDS # ... IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Opportunistic Disease in HIV-AIDS ... (TB) • Disseminated ... #OIs #HIVAIDS # ... IDSA #management ... #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Recommendations for Preventing ... Women with in HIV-AIDS ... test) is not recommended ... #Treatment #management ... #HIVAIDS #pharmacology
Initiation of ART in HIV patients with Opportunistic Infections
 • Pulmonary TB and CD4 cell count
Opportunistic Infections ... • Pulmonary TB ... count <50 • Pulmonary ... treatment By ... #management #infectiousdiseases
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... Penicillium marneffei Infections ... in HIV-AIDS Preventing ... #Treatment #management ... #HIVAIDS #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
infectionPulmonary ... • HIV: 2/3 pulmonary ... Tuberculosis Treatment ... #Diagnosis #Management ... #Treatment #ActiveTB
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Recommendations for Preventing ... in HIV-AIDS Preventing ... illness usually is ... #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Trypanosomiasis) in HIV-AIDS ... is effective in ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
infectionPulmonary ... • HIV: 2/3 pulmonary ... Tuberculosis Treatment ... #Diagnosis #Management ... #Treatment #ActiveTB
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
Here is a quick ... ) infection. ... Antivirals #table #treatment ... HepC #HepatitisC #Management ... #Pharmacology